We developed a post-processing algorithm to convert raw natural language processing output from electronic health records into a usable format for analysis. This algorithm was specifically developed for creating datasets that can be used for medication-based studies.
Introduction
Natural language processing (NLP) systems extract information from unstructured text and convert it into a structured format. The development of NLP systems for extracting information from electronic health records (EHRs) has led to great opportunities for performing diverse research using EHRs by providing critical pieces of data. Many NLP systems have been developed specifically for clinical research. For example, cTAKES [1] , MetaMap [2] , and MedLEE [3] are NLP systems for general purpose extraction of clinical information. In 1996, Evans et al. used the CLARIT system to extract medication names and dosage information from clinical narrative text. [4] Their system extracted medication dosage information with about 80% accuracy. More recently, MedEx [5] , CLAMP [6] , MedXN [7] , and medExtractR [8] , have been developed to extract medication information from EHRs more accurately, which is useful for drugbased studies.
The raw output from some of these systems is not directly usable and requires a post-processing step to convert the extracted information into an appropriate data form for further analysis depending on the research goal. For an example of medication extraction, the entities (or attributes) of the raw output from NLP systems should be associated with corresponding medication names to make dose data, such as dose given intake or daily dose, that can be used for further analysis. Some NLP systems have a built-in post-processing step as a part of the system. For example, the final step in the system built by Patrick et al. for the 2009 i2b2 medication extraction challenge was equipped with a medication entry generator for assembling medication events based on the relationships between components established in previous steps. [9] Also, the Lancet system developed by Li et al. included a supervised machine learning classifier that attempted to associate a medication name with the correct entities. [10] MedEx [5] and Clamp [6] also include a post-processing step that connects entities with each drug name in a data structure.
However, to the best of our knowledge, the validation of post-processing algorithms for these NLP systems has not been reported separately from the overall evaluation of the NLP systems in the literature, although they may be unofficially validated during the development phase. Correctly connecting entities with both drug name and with each other to obtain medication dose (e.g., dose given intake or daily dose) can be challenging and error prone if the prescription pattern is complex.
Developing and validating a post-processing algorithm separately from the main NLP system would allow for easier identification of error sources and more efficient improvement of relevant parts of the system. Thus, we developed algorithms that process the raw output from two medication extraction systems, MedXN and medExtractR, which performed best out of 4 NLP systems previously tested. [8] The post-processing algorithm we developed is divided into two parts. Part I processes the raw output from the NLP system and connects entities together. Part II removes redundant data entries anchored at each note or date identifier and calculates dose given intake and daily dose. These measurements are crucial for medication-based studies such as population pharmacokinetic and pharmacodynamic or pharmacogenomic studies.
Methods

Data source
To develop a post-processing algorithm we used two medications, tacrolimus and lamotrigine, whose prescription patterns vary from simple to complicated. For each medication, we defined a patient cohort separately using patient records in a de-identified database of clinical records derived from Vanderbilt's EHR system. For tacrolimus data, we used the same cohort (n=466) used in previous studies [11] , who were treated with tacrolimus after renal transplant. For lamotrigine data, we first identified patient records with 'lamotrigine' and 'Lamictal' (the brand name of lamotrigine) and an ICD-9-CM or ICD-10-CM (The International Classification of Diseases, Ninth and Tenth Revision, Clinical Modification) billing code for epilepsy before October 3, 2017. We further refined the cohort by selecting patients who had their first lamotrigine level between 18 and 70 years of age and at least 3 drug levels and 3 doses, which yielded the final cohort of 305 subjects. For each subject of each cohort, we identified all clinical notes generated on the same dates when drug concentration laboratory values were available, from which medication dosing information was extracted using both MedXN and medExtractR.
Medication entities extraction using existing NLP systems
MedXN
The Medication Extraction and Normalization (MedXN) system was designed to extract medication information from clinical notes and convert it into an RxNorm concept unique identifier (RxCUI). [7] This system identifies medication names and attributes, such as dosage, strength, and frequency, in clinical notes using the RxNorm dictionary and regular expressions. The attributes associated with a medication name are combined together in the RxNorm standard order and normalized to a specific RxCUI. medExtractR MedExtractR is a medication extraction algorithm built using the R programming language, and is more targeted than other more general purpose NLP systems. [8] Given a list of drug names to search for, medExtractR creates a search window around each identified drug mention within a clinical note in which to search for related drug entities.
The system shortens the search window when a medication name which is not of interest appears, to avoid extracting incorrect or irrelevant information. By default, the list of unrelated drug names is based on the RxNorm library supplemented with common abbreviations. Some drug entities are identified and extracted based on matching expressions in manually curated entity-specific dictionaries, including frequency, intake time, and dose change (keywords to indicate that a regimen may not be current). For the remaining entities, including strength, dose amount, dose (i.e., dose given intake), and time of last dose, regular expressions are used to identify common patterns for how these entities are written. Function arguments can be used to optimize drug entity extraction for a given set of clinical notes. Examples include specifying the maximum edit distance for approximate drug name matching or the length of the search window.
Description of post-processing algorithms
Converting the output from MedXN and medExtractR into a form that can be used for analysis requires post-processing. A simple post-processing method we considered formed all possible combinations of entities. For example, using this simple method on a drug mention with two strengths, two dose amounts, and two frequencies would have resulted in eight combinations of strengths, dose amounts, and frequencies.
However, we know most of these combinations are incorrect, and hence we developed a more sophisticated post-processing algorithm to give us more useful data for analysis.
Part I processes the raw NLP output and then pairs the parsed entities, as outlined along with some illustrative examples in Figure 1 . The algorithm begins with a single file that is the raw output from a NLP system, from which a drug name and its entities are isolated and converted to a standardized form [ Step 1]. The entities include strength, dose amount, route, frequency, duration, dose change, and dose given intake ("dose"). The dose change and dose entities are specific to medExtractR. Dose change includes key words such as "increase" that indicate that the dose isn't a current dose. Dose is an aggregate total dose given intake when dose amount information is not found. Note that If strength, frequency, or route is missing and there is a unique strength, frequency, or route within the same note, that strength, frequency, or route is borrowed. If there is not a unique strength within the same note, the closest preceding strength is borrowed. If there is no preceding strength, the closest strength after the missing strength is borrowed. If there is not a unique frequency or route within the same note, the most common frequency or route within the note is borrowed. Duration is only borrowed within a dose sequence. For example, a row with an intake time of "am" and no duration could borrow the duration in the row after it if that row has an intake time of "pm". Any records that are still missing strength are removed, since dose cannot be calculated in these cases [Step 6]. If records are still missing frequency or route, the most common frequency or route across all observations for that drug is imputed [Step 7]. Next, the dose given intake is computed by multiplying strength by dose amount. If there is not an intake time, the daily dose is computed by multiplying dose given intake by frequency. If there is an intake time (e.g., am, noon, or pm), the daily dose is calculated by adding the dose given intakes at each of the intake times [Step 8] . Finally, any redundancies are removed at date level and note level separately, yielding two datasets [Step 9].
Generation of training and test sets
We generated training and test sets for each medication (i.e., tacrolimus and lamotrigine) from medication entities extracted by each NLP system (i.e., MedXN and medExtractR). Each dataset included approximately 300 observations from 10 patients.
Patients with complex data were over sampled. Complexity was determined by the presence of multiple clusters or clusters containing entities with conflicting values. These cases are often difficult to process and are likely to produce discrepant daily dose. For example, when two different strengths of 100 mg and 200 mg are associated with a lamotrigine mention, they are more difficult to process compared to only a unique strength of 100 mg associated with that drug mention since each strength must be paired with the correct dose amount and frequency. Thus, for each of the training and test sets, we randomly selected a greater number of complicated cases; six of the tacrolimus patients were chosen from patients with known complications as well as eight of the lamotrigine patients.
Making gold standard datasets
For each of the training and test sets, we generated three sets of gold standard datasets to test each part of the post-processing algorithm. Each gold standard dataset was manually generated to make the intended output for each part of the algorithm. That means that we generated "Gold Standard I" as the output of Part I if the five steps of the algorithm were correctly performed. Then, we generated "Gold Standard II-Date" and "Gold Standard II-Note" as the output data of Part II applied to the Gold Standard I at date level and at note level, respectively, if the nine steps of the algorithm were correctly performed. These were generated for each of the training and test sets and each of the medications (i.e., tacrolimus and lamotrigine), yielding a total of 12 sets of gold standard datasets for each NLP system.
Evaluation of algorithms
The algorithms were evaluated using recall, precision, and F1-measure. Recall is the proportion of the gold standard entities that were correctly identified by the algorithm.
Precision is the proportion of the extracted entities that were correctly found in the gold standard. The F1-measure is defined as 2*(precision*recall)/(precision+recall).
Results
Performance
We evaluated each part of the algorithm separately. Table 1 presents the results for Part I.
The algorithm performed well on both medications for both MedXN and medExtractR.
The recall was slightly higher for tacrolimus than lamotrigine when using the MedXN output (0.96 vs. 0.94), but the precision was slightly lower for tacrolimus (0.93 vs. 0.94).
The F1-measures were the same for both medications (0.94). The algorithm performed better on the medExtractR output than the MedXN output. The tacrolimus recall/precision/F1-measure was 1.00/1.00/1.00 while lamotrigine was 0.98/0.98/0.98.
The results for Part II can be found in Table 2 . Here we present the recall, precision, and F1-measure for both medications at the note and date level, and we consider the dose intake and daily dose. The note level collapsing performed very well with all F1-measures equal to 1 for dose intake for both medications and both NLP systems, and F1-measures ranging from 0.96 to 1 for daily dose. Date level collapsing also performed well with F1-measures ranging from 0.95 to 1 for dose intake and 0.91 to 1 for daily dose. 
Error analyses and examples of challenges
When making the Gold Standard I, we sometimes paired entities based on their positions in the original note. This only happened for complicated cases when the number of each entity was not equal (e.g., three strengths and two dose amounts), which caused difficulty on our judgement for pairing; hence, we looked at the position in the original note to make the pairing decision. Since Part I only used position to make the clusters but did not use information about the position of the entities when pairing, rather it used order, this sometimes resulted in disagreement between the gold standard and the algorithm. Table 3 presents an example of this case. In this example, there are three strengths and four frequencies in the MedXN output. The algorithm pairs them in order, but the Gold Standard I paired them based on position.
Another challenge occurred when the NLP extracted incorrect information. This could have occurred because of a misspelling, missing spaces, or an uncommon abbreviation of a drug name, which caused the NLP to extract entities anchored to the wrong drug mention. This results in several extra strengths, dose amounts, or frequencies, making for a very complicated cluster structure. Table 4 illustrates this example. Here, all of the information that was extracted by MedXN was incorrect because of the missing spaces between the frequencies and the next drug name.
Also, the gap size of 32 occasionally caused issues for pairing in Part I. As an example, Table 5 shows that the first cluster includes the strength of 100 mg and the frequency of bid, the second cluster includes the first dose amount of 2 and the frequency of daily, and the third cluster includes the second dose amount of 2, so the output has three rows. However, because there were two dose amounts and two frequencies, these entities were paired in order in the Gold Standard I.
In Part II, challenges occurred when the morning dose came after the evening dose. The algorithm only treated dose sequences correctly when the morning dose came before the evening dose.
Discussion
Detailed medication dose information is often required to perform medicationbased population studies. Medication dose data can be obtained from a structured data source or an unstructured data source such as clinical notes in EHRs. To extract medication dose information from unstructured text, a specialized algorithm such as a natural language processing system is commonly used. However, the output of NLP systems is often not in a form that is useful for analysis. We developed a post-processing algorithm to address this issue. Our algorithm consists of two parts to parse raw NLP output, connect medication names and attributes, and eliminate redundant information.
Our post-processing algorithm was developed using the output from two NLP systems, MedXN and medExtractR. Our algorithm performed reasonably well to process the output from both MedXN (F-measures Part I: ³ 0.94; Part II: ³ 0.98) and medExtractR (F-measures Part I: ³ 0.98; Part II: ³ 0.91). We tested the algorithm using two medications that have widely different prescribing patterns, but it should be tested using other medications. We also have Part I written for two other NLP systems, MedEx and CLAMP, but we have not yet tested the algorithm using a gold standard for these systems. We are in the process of incorporating a few changes to the algorithm, such as pairing entities based on distance in Part I in order to improve the performance.
The goal of the post-processing algorithm was to convert all the extracted information from an NLP system into a usable format. However, this may result in conflicting doses on the same day, which will need to be resolved before the data can be used for medication-based studies such as pharmacokinetic or pharmacodynamic studies.
Future work will focus on identifying the most likely correct dose when conflicting doses are present.
